Multicenter evaluation of Tosoh glycohemoglobin analyzer

Clinical Chemistry

Volumn 45, Issue 10, 1999, Pages 1833-1841

  Gibb, Ian ^a   Parnham, Angela ^a   Fonfrède, Michele ^b   Lecock, Freddy ^c  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Eurogenetics   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

ANALYTIC METHOD; ARTICLE; AUTOANALYZER; CHROMATOGRAPHY; CONTROLLED STUDY; DEVICE; DIABETES MELLITUS; DIAGNOSTIC VALUE; HEMOGLOBIN ANALYSIS; HUMAN; INTERMETHOD COMPARISON;

EID: 0032878559     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.10.1833     Document Type: Article

References (18)

1. 1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. 2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
3. 3. Peters AL, Davidson MB, Schringer DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. JAMA 1996;276:1246-52.
4. 4. Goldstein DE, Little RR, Weidmeyer HM, England JD, Rohlfing CL. Glycated hemoglobin estimation in the 1990s: a review of assay methods and clinical interpretation. In: Marshall SM, Home PD, eds. The diabetes annual/8. Amsterdam: Elsevier Science, 1994: 193-212.
5. 5. Commission for validation of methods of the Societe Francaise de Biologie Clinique. Protocol for the validation of methods. Ann Biol Clin 1986;44:686-745.
6. 6. Broughton PMG, Gowanlock AH, McCormack JJ, Neill DW. A revised scheme for the evaluation of automatic instruments for use in clinical chemistry. Ann Clin Biochem 1974;11:207-14.
7. 7. Langdown JV, Williamson D, Beresford CH, Gibb I, Taylor R, Deacon-Smith R. A new β chain variant, HbTyne [β5(A2)Pro→ser]. Hemoglobin 1994;18:333-6.
8. 8. Fraser CG, Hyltoft Petersen P, Larsen ML. Setting analytical goals for random analytical error in specific clinical monitoring situations. Clin Chem 1990;36:1625-8.
9. 9. Phillipou G, Phillips PJ. Intraindividual variation of glycohemoglobin: implications for interpretation and analytical goals. Clin Chem 1993;39:2305-8.
10. 10. Kolatkar NS, Cembrowski GS, Callahan PL, Etzwiler DD. Intensive diabetes management requires very precise testing of glycohemoglobin [Letter]. Clin Chem 1994;8:1608-9.
11. 11. Anonymous. American Diabetes Association (ADA) position statement. Tests of glycemia in diabetes. Diabetes Care 1997;20(Suppl 1):S18-20.
12. 12. Mullins RE, Austin GE. Sensitivity of iso-electric focusing, ion exchange and affinity chromatography to labile glycated hemoglobin. Clin Chem 1986;32:1460-3.
13. 13. Bannon P, Jolly JG, Lessard F, Lepage R. Comparison of three methods for the elimination of the labile fraction of HbA1. Clin Biochem 1985;18:114-7.
14. 14. John WG, Braconnier F, Miedema K, Aulesa C, Piras G. Evaluation of the Menarini-Arkray HA8140 hemoglobin A1c analyzer. Clin Chem 1997;43:968-75.
15. 15. Ellis G. Incomplete removal of labile fraction when measuring hemoglobin A1c with the Bio·Rad Variant analyzer [Letter]. Clin Chem 1997;43:2437-8.
16. 16. Chevenne D, Fonfrede M, Ducrocq R, Chauffent M, Trivin F. Uremia and HbA1c measured by high-performance liquid chromatography [Letter]. Diabetes Care 1998;21:463-4.
17. 17. Weykamp CW, Penders TJ, Siebetder CWM, Muskiet FJ, van der Slik W. Interference of carbamylated and acetytated hemoglobins in assays of glycohemoglobin by HPLC, electrophoresis, affinity chromatography and enzyme immunoassay. Clin Chem 1993;39:138-42.
18. 18. Diem P, Mullis P, Hirt P. Fetal hemoglobin levels in adult type I (insulin dependent) diabetes mellitus, Diabetologia 1993;36:129-32.